Related Experiment Video
Updated: Jun 8, 2026
07:30
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
The leptin system: a potential target for sepsis induced immune suppression
Johannes Tschöp1, Jonathan R Dattilo, Priya S Prakash
1Department of Surgery, University of Cincinnati College of Medicine, OH 45267, USA.
Endocrine, Metabolic & Immune Disorders Drug Targets
|October 7, 2010
Summary
Sepsis treatment remains challenging due to immune paralysis. Leptin, a hormone, shows potential to enhance immune response and host defense during sepsis, offering a new therapeutic avenue.
Area of Science:
- Immunology
- Endocrinology
- Critical Care Medicine
Background:
- Sepsis is a life-threatening condition characterized by dysregulated host response to infection.
- Current sepsis treatments lack convincing efficacy in reducing mortality.
- Immune paralysis during sepsis impairs the host's ability to fight infections.
Purpose of the Study:
- To review the expression and function of leptin and its receptor on leukocytes.
- To examine the effects of leptin in sepsis, both centrally and systemically.
- To evaluate leptin's potential as a therapeutic agent for sepsis.
Main Methods:
- Review of existing literature on leptin, its receptor, and immune cell signaling.
- Analysis of studies investigating leptin's role in the context of sepsis.
- Examination of evidence for leptin's immunomodulatory effects.
Main Results:
- Leptin levels fluctuate during sepsis, initially increasing then declining.
- Leptin and its receptor are expressed and functional on leukocytes.
- Evidence suggests leptin can beneficially regulate immune function.
Conclusions:
- Leptin's ability to enhance inflammation and host response in sepsis is supported by evidence.
- Leptin may serve as a valuable therapeutic agent, especially in later stages of sepsis.
- Further research into leptin's therapeutic potential in sepsis is warranted.
